MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 134 filers reported holding MERSANA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,368,032 | +6.6% | 5,801,600 | +176.3% | 2.23% | +4.5% |
| Q2 2023 | $6,909,000 | +211.3% | 2,100,000 | +288.8% | 2.14% | +133.3% |
| Q1 2023 | $2,219,642 | -66.8% | 540,059 | -52.6% | 0.92% | -52.1% |
| Q4 2022 | $6,681,467 | -0.6% | 1,140,182 | +14.7% | 1.91% | -15.9% |
| Q3 2022 | $6,720,000 | +71.1% | 994,073 | +16.9% | 2.27% | +88.0% |
| Q2 2022 | $3,927,000 | +131.1% | 850,000 | +579.3% | 1.21% | +59.5% |
| Q2 2021 | $1,699,000 | +319.5% | 125,123 | +400.5% | 0.76% | +243.0% |
| Q1 2021 | $405,000 | +41.6% | 25,000 | +132.3% | 0.22% | +33.1% |
| Q4 2020 | $286,000 | – | 10,763 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |